Effects of Topically Administered Neuroprotective Drugs in Early Stages of Diabetic Retinopathy: Results of the EUROCONDOR Clinical Trial.

Saved in:
Bibliographic Details
Title: Effects of Topically Administered Neuroprotective Drugs in Early Stages of Diabetic Retinopathy: Results of the EUROCONDOR Clinical Trial.
Authors: Simó R; Diabetes and Metabolism Research Unit and CIBERDEM, Vall d'Hebron Research Institute, Barcelona, Spain rafael.simo@vhir.org cunhavaz@aibili.pt., Hernández C; Diabetes and Metabolism Research Unit and CIBERDEM, Vall d'Hebron Research Institute, Barcelona, Spain., Porta M; Department of Medical Sciences, University of Turin, Turin, Italy., Bandello F; Department of Ophthalmology, University Vita-Salute, Scientific Institute San Raffaele, Milano, Italy., Grauslund J; Research Unit of Ophthalmology, Department of Clinical Research, University of Southern Denmark, Odense, Denmark., Harding SP; Department of Eye and Vision Science, Institute of Ageing and Chronic Disease, University of Liverpool, Liverpool, U.K., Aldington SJ; Gloucestershire Hospitals National Health Service Foundation Trust, Cheltenham, U.K., Egan C; Moorfields Eye Hospital National Health Service Foundation Trust, Institute of Ophthalmology/University College London, London, U.K., Frydkjaer-Olsen U; Research Unit of Ophthalmology, Department of Clinical Research, University of Southern Denmark, Odense, Denmark., García-Arumí J; Department of Ophthalmology, Vall d'Hebron University Hospital, Barcelona, Spain., Gibson J; Department of Vision Sciences, Aston University, Birmingham, U.K., Lang GE; Department of Ophthalmology, University of Ulm, Ulm, Germany., Lattanzio R; Department of Ophthalmology, University Vita-Salute, Scientific Institute San Raffaele, Milano, Italy., Massin P; Department of Ophthalmology, Lariboisière Hospital, Paris, France., Midena E; Department of Ophthalmology, University of Padova, Padova, Italy., Ponsati B; BCN Peptides, Barcelona, Spain., Ribeiro L; Association for Innovation and Biomedical Research on Light and Image (AIBILI), Coimbra, Portugal, and Faculty of Medicine, University of Coimbra, Ophthalmology Department, Centro Hospitalar e Universitário de Coimbra (CHUC), Coimbra, Portugal., Scanlon P; Gloucestershire Hospitals National Health Service Foundation Trust, Cheltenham, U.K., Lobo C; Association for Innovation and Biomedical Research on Light and Image (AIBILI), Coimbra, Portugal, and Faculty of Medicine, University of Coimbra, Ophthalmology Department, Centro Hospitalar e Universitário de Coimbra (CHUC), Coimbra, Portugal., Costa MÂ; Association for Innovation and Biomedical Research on Light and Image (AIBILI), Coimbra, Portugal, and Faculty of Medicine, University of Coimbra, Ophthalmology Department, Centro Hospitalar e Universitário de Coimbra (CHUC), Coimbra, Portugal., Cunha-Vaz J
Corporate Authors: European Consortium for the Early Treatment of Diabetic Retinopathy (EUROCONDOR)
Source: Diabetes [Diabetes] 2019 Feb; Vol. 68 (2), pp. 457-463. Date of Electronic Publication: 2018 Nov 02.
Publication Type: Clinical Trial, Phase II; Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
Journal Info: Publisher: American Diabetes Association Country of Publication: United States NLM ID: 0372763 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1939-327X (Electronic) Linking ISSN: 00121797 NLM ISO Abbreviation: Diabetes
Database: MEDLINE Ultimate
Description
ISSN:1939-327X
DOI:10.2337/db18-0682